| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |